Redox Report (Dec 2024)

Implication of endoplasmic reticulum stress and mitochondrial perturbations in remote liver injury after renal ischemia/reperfusion in rats: potential protective role of azilsartan

  • Rania A. Elrashidy,
  • Esraa M. Zakaria,
  • Rehab A. Hasan,
  • Asmaa M. Elmaghraby,
  • Dina A. Hassan,
  • Ranya M. Abdelgalil,
  • Shaimaa R. Abdelmohsen,
  • Amira M. Negm,
  • Azza S. Khalil,
  • Ayat M. S. Eraque,
  • Reem M. Ahmed,
  • Walaa S. Sabbah,
  • Ahmed A. Ahmed,
  • Samah E. Ibrahim

DOI
https://doi.org/10.1080/13510002.2024.2319963
Journal volume & issue
Vol. 29, no. 1

Abstract

Read online

Objectives: Distant liver injury is a complication of renal ischemia-reperfusion (I/R) injury, which imposes mortality and economic burden. This study aimed to elucidate the cross-talk of endoplasmic reticulum (ER) stress and mitochondrial perturbations in renal I/R-induced liver injury, and the potential hepatoprotective effect of azilsartan (AZL).Methods: Male albino Wister rats were pre-treated with AZL (3 mg/kg/day, PO) for 7 days then a bilateral renal I/R or sham procedure was performed. Activities of liver enzymes were assessed in plasma. The structure and ultra-structure of hepatocytes were assessed by light and electron microscopy. Markers of ER stress, mitochondrial biogenesis and apoptosis were analyzed in livers of rats.Results: Renal ischemic rats showed higher plasma levels of liver enzymes than sham-operated rats, coupled with histological and ultra-structural alterations in hepatocytes. Mechanistically, there was up-regulation of ER stress markers and suppression of mitochondrial biogenesis-related proteins and enhanced apoptosis in livers of renal ischemic rats. These abnormalities were almost abrogated by AZL pretreatment.Discussion: Our findings uncovered the involvement of mitochondrial perturbations, ER stress and apoptosis in liver injury following renal I/R, and suggested AZL as a preconditioning strategy to ameliorate remote liver injury in patients susceptible to renal I/R after adequate clinical testing.

Keywords